Nonalcoholic fatty liver disease.
NAFLD likely is the most common liver disease in children and is responsible for significant progression to cirrhosis, portal hypertension, and the need for liver transplantation in adults and even in some adolescents. Early diagnosis and lifestyle interventions appear to be our best hope for controlling progression of disease. The pediatrician is responsible for screening all obese children with measurement of aminotransferases. Those with elevated enzymes (particularly ALT) for longer than 3 months, in the absence of markers of hepatitis B or C, autoimmune chronic active hepatitis, Wilson's disease, hemochromatosis, or alpha-1-antitrypsin deficiency, should follow up with an abdominal ultrasound. In patients with a BMI in the morbidly obese range, an ultrasound to search for a diffusely echogenic liver should be performed even if the liver enzymes are normal. Findings suggestive of NAFLD should prompt the institution of appropriate dietary and exercise regimens. If these are unsuccessful after a 3-month trial, the patient should be referred to a pediatric gastroenterologist and hepatologist for further work-up and treatment, preferably in the context of a controlled therapeutic trial. Only by aggressively engaging this current epidemic will we be able to decrease the mounting human cost of NAFLD.
Alfire
Marcos E
ME
Division of Pediatric Gastroenterology, Hepatology, and Nutrition, State University of New York Downstate Medical Center, Brooklyn 11203-2098, USA.
Treem
William R
WR
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005234:Fatty Liver / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D005260:Female; D006630:Hispanic or Latino; D006801:Humans; D007223:Infant; D008297:Male; D009765:Obesity / Q000150:complications*; D015995:Prevalence; D000637:Transaminases / Q000097:blood
D000637:Transaminases